Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2004 Mar;141(5):775-85.
doi: 10.1038/sj.bjp.0705667. Epub 2004 Feb 2.

Cannabinoids and neuroinflammation

Lisa Walter  1 , Nephi Stella
Affiliations
Review

Cannabinoids and neuroinflammation

Lisa Walter et al. Br J Pharmacol. 2004 Mar.

Abstract

Growing evidence suggests that a major physiological function of the cannabinoid signaling system is to modulate neuroinflammation. This review discusses the anti-inflammatory properties of cannabinoid compounds at molecular, cellular and whole animal levels, first by examining the evidence for anti-inflammatory effects of cannabinoids obtained using in vivo animal models of clinical neuroinflammatory conditions, specifically rodent models of multiple sclerosis, and second by describing the endogenous cannabinoid (endocannabinoid) system components in immune cells. Our aim is to identify immune functions modulated by cannabinoids that could account for their anti-inflammatory effects in these animal models.

PubMed Disclaimer

References

    1. ABOOD M.E., RIZVI G., SALLAPUDI N., MCALLISTER S.D. Activation of the CB1 cannabinoid receptor protects cultured mouse spinal neurons against excitotoxicity. Neurosci. Lett. 2001;309:197–201. - PubMed
    1. AREVALO-MARTIN A., VELA J.M., MOLINA-HOLGADO E., BORRELL J., GUAZA C. Therapeutic action of cannabinoids in a murine model of multiple sclerosis. J. Neurosci. 2003;23:2511–2516. - PMC - PubMed
    1. BAKER D., PRYCE G., CROXFORD J.L., BROWN P., PERTWEE R.G., HUFFMAN J.W., LAYWARD L. Cannabinoids control spasticity and tremor in a multiple sclerosis model. Nature. 2000;404:84–87. - PubMed
    1. BAKER D., PRYCE G., CROXFORD J.L., BROWN P., PERTWEE R.G., MAKRIYANNIS A., KHANOLKAR A., LAYWARD L., FEZZA F., BISOGNO T., DI MARZO V. Endocannabinoids control spasticity in a multiple sclerosis model. FASEB J. 2001;15:300–302. - PubMed
    1. BAYEWITCH M., AVIDOR-REISS T., LEVY R., BARG J., MECHOULAM R., VOGEL Z. The peripheral cannabinoid receptor: adenylate cyclase inhibition and G protein coupling. FEBS Lett. 1995;375:143–147. - PubMed

Publication types

MeSH terms